Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Technische Universität Dresden.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Jörg Kotzerke, Dresden University of Technology
ClinicalTrials.gov Identifier:
First received: September 13, 2005
Last updated: August 23, 2011
Last verified: August 2011
The purpose of the study is to describe the regional and global FDG-kinetics in head and neck cancer during percutaneous radiation therapy.

Head and Neck Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 50
Study Start Date: July 2005

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study includes consecutive patients from the Department of Radiooncology with head and neck cancer (HNC) intended for a curative chemoradiotherapy.

Inclusion Criteria:

  • Histologically confirmed head and neck cancer not curable by surgery
  • Karnofsky > 70%
  • Tumor volume and localization allow curative radiotherapy
  • Written consent

Exclusion Criteria:

  • Metastases
  • Earlier radiotherapy of head or neck
  • Pregnancy
  • Secondary malignancy excluding dermal carcinoma T1 and Tis-carcinoma of cervix uteri
  • Psychiatric impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00180245

Contact: Joerg Kotzerke, MD +49 351 458 4160 Joerg.Kotzerke@uniklinikum-dresden.de

Department of Nuclear Medicine Recruiting
Dresden, Germany, 01307
Contact: Joerg Kotzerke, MD    +49 351 458 4160    Joerg.Kotzerke@uniklinikum-dresden.de   
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Joerg Kotzerke, MD Department of Nuclear Medicine
  More Information

No publications provided

Responsible Party: Jörg Kotzerke, Prof. Dr., Dresden University of Technology
ClinicalTrials.gov Identifier: NCT00180245     History of Changes
Other Study ID Numbers: HNO-FDG-FU 
Study First Received: September 13, 2005
Last Updated: August 23, 2011
Health Authority: Germany: Federal Office for Radiation Protection

Keywords provided by Technische Universität Dresden:
Radiation therapy

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on February 09, 2016